GSV Capital Corp. Reports Fourth Quarter and Fiscal Year 2017 Financial Results
Mar 13, 2018 20:05 pm UTC| Business
WOODSIDE, Calif., March 13, 2018 -- GSV Capital Corp. (“GSV Capital” or the “Company”) (Nasdaq:GSVC) today announced financial results for the quarter and fiscal year ended December 31, 2017. Net assets totaled...
Athersys Reports Financial Results for Fourth Quarter, Full Year 2017
Mar 13, 2018 20:05 pm UTC| Business
Company also announces equity investment and binding letter of intent to expand HEALIOS K.K. collaboration, covered in a separate release Management to host conference call at 4:30 PM EDT today CLEVELAND, March 13,...
Mar 13, 2018 20:05 pm UTC| Business
IRVINE, Calif., March 13, 2018 -- Impac Mortgage Holdings, Inc. (NYSE American:IMH), announces the scheduling of a conference call and live webcast on Thursday, March 15, 2018 at 9:00 a.m. P.T. (12:00 p.m. E.T.). We...
PetIQ, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 13, 2018 20:05 pm UTC| Business
EAGLE, Idaho, March 13, 2018 -- PetIQ, Inc. (“PetIQ” or the “Company”) (NASDAQ:PETQ), a leading pet medication and wellness company, today reported financial results for its fourth quarter and year ended December 31,...
Navios Maritime Containers Inc. Announces Closing of $30.0 Million Private Placement
Mar 13, 2018 20:05 pm UTC| Business
MONACO, March 13, 2018 -- Navios Maritime Containers Inc. (“Navios Containers”) (N-OTC:NMCI), a growth vehicle dedicated to the container sector, announced today that it has closed the private placement of common shares...
Everi Reports 2017 Fourth Quarter and Full Year Results
Mar 13, 2018 20:05 pm UTC| Business
Q4 Revenues of $247.9 Million, Net Loss of $25.0 Million, Inclusive of a $37.1 Million Loss on Extinguishment of Debt, and Adjusted EBITDA of $51.3 Million Provides Outlook for 2018 Revenue and Adjusted EBITDA Growth ...
Immunovaccine to Host Investor Event on April 10, 2018 in New York City
Mar 13, 2018 20:05 pm UTC| Business
HALIFAX, Nova Scotia, March 13, 2018 -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology company, announced today that it will host an RD Update and Investor Event for the investment...